OVCAR-3 spheroid-derived cells display distinct metabolic profiles

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Vermeersch, Kathleen A ^a   Wang, Lijuan ^b   Mezencev, Roman ^b   McDonald, John F ^b   Styczynski, Mark P ^a  

^a Georgia Institute of Technology   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ARGININE; ASPARTIC ACID; BIOLOGICAL MARKER; ERYTHRONIC ACID; FUMARIC ACID; GLUTAMIC ACID; ISOLEUCINE; PROLINE; PSICOSE; PUTRESCINE; PYROPHOSPHATE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; URIDINE PHOSPHATE;

AMINO ACID METABOLISM; ARTICLE; CANCER STEM CELL; CARBOHYDRATE METABOLISM; CELL METABOLISM; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; DRUG RESISTANCE; GENE EXPRESSION; GENE SET ENRICHMENT ANALYSIS; GENETIC ANALYSIS; IN VITRO STUDY; MASS FRAGMENTOGRAPHY; METABOLOMICS; OVARIAN CANCER CELL LINE; OVARIAN CANCER STEM CELL; OVCAR 3 CELL LINE; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; RADIOSENSITIVITY; SEPARATION TECHNIQUE; SPHEROID CELL; SPHEROID DERIVED CELL; TRANSCRIPTION REGULATION; HUMAN; METABOLISM; MULTICELLULAR SPHEROID; NEOPLASM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; HUMANS; METABOLOMICS; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PHENOTYPE; PROLINE; PUTRESCINE; SPHEROIDS, CELLULAR;

EID: 84923280721     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118262     Document Type: Article

References (65)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: A Cancer Journal for Clinicians. 2012;62(1):10-29. doi: 10.3322/caac.20138.
2. Herzog TJ. Recurrent Ovarian Cancer: How Important Is It to Treat to Disease Progression? Clinical Cancer Research. 2004;10(22):7439-49. doi: 10.1158/1078-0432. CCR-04-0683 PMID: 15569973
3. Fong MY, Kakar SS. The role of cancer stem cells and the side population in epithelial ovarian cancer. Histology and Histopathology. 2010;25(1):113-20. PMID: 19924647
4. Gao Q L, Geng L, Kvalheim G, Gaudernack G, Suo ZH. Identification of Cancer Stem-like Side Population Cells in Ovarian Cancer Cell Line OVCAR-3. Ultrastruct Pathol. 2009;33(4):175-81. doi: 10.1080/01913120903086072 PMID: 19728235
5. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183(4):1797-806. PMID: 8666936
6. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8(10):755-68. doi: 10.1038/nrc2499 PMID: 18784658
7. Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell cycle. 2009;8(1):158-66. 7533 [pii]. PMID: 19158483
8. Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF. Isolation and characterization of stemlike cells from a human ovarian cancer cell line. MolCell Biochem. 2012;363(1-2):257-68. doi: 10. 1007/s11010-011-1178-6 PMID: 22231842
9. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462(7274):739-U52. doi: 10.1038/nature08617 PMID: 19935646
10. Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, Souza A L, et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science. 2012;336(6084):1040-4. doi: 10.1126/science.1218595 PMID: 22628656
11. Zhou M, Guan W, Walker LD, Mezencev R, Benigno BB, Gray A, et al. Rapid Mass Spectrometric Metabolic Profiling of Blood Sera Detects Ovarian Cancer with High Accuracy. Cancer Epidemiology Biomarkers & Prevention. 2010;19 (9:). doi: 10.1158/1055-9965.epi-10-0126 PMID: 25613532
12. Zhang T, Wu X, Ke C, Yin M, Li Z, Fan L, et al. Identification of Potential Biomarkers for Ovarian Cancer by Urinary Metabolomic Profiling. J Proteome Res. 2013;12(1):505-12. doi: 10.1021/pr3009572 PMID: 23163809
13. Kim TH, Suh DH, Kim MK, Song YS. Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer. BioMed research international. 2014;2014:132702. doi: 10.1155/2014/132702 PMID: 25050322
14. Vlashi E, Pajonk F. The metabolic state of cancer stem cells-a valid target for cancer therapy? Free radical biology & medicine. 2014. doi: 10.1016/j.freeradbiomed.2014.10.732.
15. Xie H, Hanai J, Ren JG, Kats L, Burgess K, Bhargava P, et al. Targeting lactate dehydrogenase-a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. Cell metabolism. 2014;19(5):795-809. doi: 10.1016/j.cmet.2014.03.003 PMID: 24726384
16. Mlynarik V, Cudalbu C, Clement V, Marino D, Radovanovic I, Gruetter R. In vivo metabolic profiling of glioma-initiating cells using proton magnetic resonance spectroscopy at 14.1 Tesla. NMRin biomedicine. 2012;25(4):506-13. doi: 10.1002/nbm.1763 PMID: 21796713
17. Ciavardelli D, Rossi C, Barcaroli D, Volpe S, Consalvo A, Zucchelli M, et al. Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment. Cell death & disease. 2014;5:e1336. doi: 10.1038/cddis.2014.285 PMID: 25616257
18. Vincent Z, Urakami K, Maruyama K, Yamaguchi K, Kusuhara M. CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile. Genes & cancer. 2014;5(7-8):250-60. doi: 10.1016/j.micpath.2015.01. 006 PMID: 25616260
19. D'Aguanno S, Barcaroli D, Rossi C, Zucchelli M, Ciavardelli D, Cortese C, et al. p63 isoforms regulate metabolism of cancer stem cells. Journal of proteome research. 2014;13(4):2120-36. doi: 10.1021/pr4012574 PMID: 24597989
20. Feng W, Gentles A, Nair RV, Huang M, Lin Y, Lee CY, et al. Targeting unique metabolic properties of breast tumor initiating cells. Stem cells. 2014;32(7):1734-45. doi: 10.1002/stem.1662 PMID: 24497069
21. Isayev O, Rausch V, Bauer N, Liu L, Fan P, Zhang Y, et al. Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. Oncotarget. 2014;5(13):5177-89. PMID: 25015789
22. Liao J, Qian F, Tchabo N, Mhawech-Fauceglia P, Beck A, Qian Z, et al. Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoSOne. 2014;9(1):e84941. doi: 10.1371/journal.pone. 0084941 PMID: 24409314
23. Liu PP, Liao J, Tang Z J, Wu WJ, Yang J, Zeng ZL, et al. Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway. Cell death and differentiation. 2014;21(1):124-35. doi: 10.1038/cdd.2013.131 PMID: 24096870
24. Palorini R, Votta G, Balestrieri C, Monestiroli A, Olivieri S, Vento R, et al. Energy metabolism characterization of a novel cancer stem cell-like line3AB-OS. Journal of cellular biochemistry. 2014;115(2):368-79. doi: 10.1002/jcb.24671 PMID: 24030970
25. Shen YA, Wang CY, Hsieh YT, Chen YJ, Wei YH. Metabolic Reprogramming Orchestrates Cancer Stem Cell Properties in Nasopharyngeal Carcinoma. Cell cycle. 2014:0. doi: 10.4161/15384101.2014. 974419.
26. Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou M, et al. Metabolic state of glioma stem cells and nontumorigenic cells. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(38):16062-7. doi: 10.1073/pnas.1106704108 PMID: 21900605
27. Vlashi E, Lagadec C, Vergnes L, Reue K, Frohnen P, Chan M, et al. Metabolic differences in breast cancer stem cells and differentiated progeny. Breast cancer research and treatment. 2014;146(3):525-34. doi: 10.1007/s10549-014-3051-2 PMID: 25007966
28. Anderson AS, Roberts PC, Frisard MI, Hulver MW, Schmelz EM. Ovarian tumor-initiating cells display a flexible metabolism. Experimental cell research. 2014;328(1):44-57. doi: 10.1016/j.yexcr.2014.08. 028 PMID: 25172556
29. Cipolleschi MG, Marzi I, Santini R, Fredducci D, Vinci MC, D'Amico M, et al. Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. Cell cycle. 2014;13(2):268-78. doi: 10.4161/cc.27031 PMID: 24200964
30. Gammon L, Biddle A, Heywood HK, Johannessen AC, Mackenzie IC. Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism. PLoSOne. 2013;8(4):e62493. doi: 10.1371/journal.pone.0062493 PMID: 23638097
31. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74. S0092-8674 (11) 00127-9 [pii]. doi: 10.1016/j.cell.2011.02.013 PMID: 21376230
32. Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, et al. Characterization of a human ovarian carcinoma cell line (NIH: OVCAR-3) with androgen and estrogen receptors. Cancer research. 1983;43(11):5379-89. PMID: 6604576
33. Lu X, Bennet B, Mu E, Rabinowitz J, Kang Y. Metabolomic Changes Accompanying Transformation and Acquisition of Metastatic Potential in a Syngeneic Mouse Mammary Tumor Model. J Biol Chem. 2010;285(13):9317-21. doi: 10.1074/jbc. C110.104448 PMID: 20139083
34. Teja-Isavadharm P, Siriyanonda D, Siripokasupkul R, Apinan R, Chanarat N, Lim A, et al. A Simplified Liquid Chromatography-Mass Spectrometry Assay for Artesunate and Dihydroartemisinin, Its Metabolite, in Human Plasma. Molecules. 2010;15(12):8747-68. doi: 10.3390/molecules15128747 PMID: 21124272
35. Kind T, Wohlgemuth G, Lee DY, Lu Y, Palazoglu M, Shahbaz S, et al. FiehnLib: Mass Spectral and Retention Index Libraries for Metabolomics Based on Quadrupole and Time-of-Flight Gas Chromatography/Mass Spectrometry. Anal Chem. 2009;81(24):10038-48. doi: 10.1021/ac9019522 PMID: 19928838
36. Wei X, Shi X, Koo I, Kim S, Schmidt RH, Arteel GE, et al. MetPP: a computational platform for comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics. Bioinformatics (Oxford, England). 2013;29(14):1786-92. doi: 10.1093/bioinformatics/btt275 PMID: 23665844
37. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6(7):1060-83. doi: 10.1038/nprot.2011.335 PMID: 21720319
38. Xia JG, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS. MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Research. 2012;40(W1):W127-W33. doi: 10.1093/nar/gks374 PMID: 22553367
39. Wallace H, Fraser A, Hughes A. A perspective of polyamine metabolism. Biochem J. 2003;376:1-14. PMID: 13678416
40. Igarashi K, Kashiwagi K. Modulation of cellular function by polyamines. The International Journal of Biochemistry & Cell Biology. 2010;: 42(1):39-51. doi: 10.1016/j.biocel.2009.07.009 PMID: 25595463
41. Gerner EW, Meyskens FL Jr. Polyamines and cancer: old molecules, new understanding. Nature reviews Cancer. 2004;4(10):781-92. doi: 10.1038/nrc1454 PMID: 15510159
42. Battaglia V, De Stefano Shields C, Murray-Stewart T, Casero RA. Polyaminecatabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention. Amino Acids. 2013. doi: 10.1007/s00726-013-1529-6.
43. Casero RA, Marton LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nature Reviews Drug Discovery. 2007;6(5):373-90. doi: 10.1038/nrd2243 PMID: 17464296
44. Phang JM, Donald SP, Pandhare J, Liu Y. The metabolism of proline, a stress substrate, modulates carcinogenic pathways. Amino Acids. 2008;35(4):681-90. doi: 10.1007/s00726-008-0063-4 PMID: 18401543
45. Phang JM, Liu W, Hancock C. Bridging epigenetics and metabolism: Role of non-essential amino acids. Epigenetics. 2013;8 (3). doi: 10.4161/epi.24042 PMID: 23428843
46. Phang JM, Liu W. Proline metabolism and cancer. Frontiers in Bioscience-Landmark. 2012;17:1835-45. doi: 10.2741/4022 PMID: 22201839
47. Liu W, Le A, Hancock C, Lane AN, Dang CV, Fan TW-M, et al. Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proceedings of the National Academy of Sciences. 2012;109(23):8983-8. doi: 10. 1073/pnas.1203244109 PMID: 22615405
48. Washington JM, Rathjen J, Felquer F, Lonic A, Bettess MD, Hamra N, et al. L-Proline induces differentiation of ES cells: a novel role for an amino acid in the regulation of pluripotent cells in culture. AJP: Cell Physiology. 2010;298(5):C982-C92. doi: 10.1152/ajpcell.00498.2009 PMID: 20164384
49. Casalino L, Comes S, Lambazzi G, De Stefano B, Filosa S, De Falco S, et al. Control of embryonic stem cell metastability by L-proline catabolism. Journal of Molecular Cell Biology. 2011;3(2):108-22. doi: 10.1093/jmcb/mjr001 PMID: 21307025
50. Comes S, Gagliardi M, Laprano N, Fico A, Cimmino A, Palamidessi A, et al. L-Proline Induces a Mesenchymal-like Invasive Program in Embryonic Stem Cells by Remodeling H3K9 and H3K36 Methylation. Stem cell reports. 2013;1(4):307-21. doi: 10.1016/j.stemcr.2013.09.001 PMID: 24319666
51. Lee M J, Chen Y, Huang YP, Hsu YC, Chiang LH, Chen TY, et al. Exogenous polyamines promote osteogenic differentiation by reciprocally regulating osteogenic and adipogenic gene expression. Journal of cellular biochemistry. 2013;114(12):2718-28. doi: 10.1002/jcb.24620 PMID: 23794266
52. Sugiura M, Shafman T, Kufe D. Effects of polyamine depletion on proliferation and differentiation of murine erythroleukemia cells. Cancer research. 1984;44(4):1440-4. PMID: 6423275
53. Erwin BG, Bethell DR, Pegg AE. Role of polyamines in differentiation of 3T3-L1 fibroblasts into adipocytes. The American journal of physiology. 1984;246(3 Pt 1):C293-300.
54. Ewton DZ, Erwin BG, Pegg AE, Florini JR. The role of polyamines in somatomedin-stimulated differentiation of L6 myoblasts. Journal of cellular physiology. 1984;120(3):263-70. doi: 10.1002/jcp. 1041200302 PMID: 6430921
55. Hyvonen MT, Koponen T, Weisell J, Pietila M, Khomutov AR, Vepsalainen J, et al. Spermidine promotes adipogenesis of 3T3-L1 cells by preventing interaction of ANP32with HuRand PP2A. The Biochemical journal. 2013;453(3):467-74. doi: 10.1042/BJ20130263 PMID: 23672317
56. Vuohelainen S, Pirinen E, Cerrada-Gimenez M, Keinanen TA, Uimari A, Pietila M, et al. Spermidine is indispensable in differentiation of 3T3-L1 fibroblasts to adipocytes. Journal of cellular and molecular medicine. 2010;14(6B):1683-92. doi: 10.1111/j.1582-4934.2009.00808.x PMID: 19538475
57. Meissen JK, Yuen BTK, Kind T, Riggs JW, Barupal DK, Knoepfler PS, et al. Induced Pluripotent Stem Cells Show Metabolomic Differences to Embryonic Stem Cells in Polyunsaturated Phosphatidylcholines and Primary Metabolism. PLoSONE. 2012;7(10):e46770. doi: 10.1371/journal.pone.0046770. s005 PMID: 23077522
58. Menendez JA, Alarcon T. Metabostemness: a new cancer hallmark. Frontiers in oncology. 2014;4:262. doi: 10.3389/fonc.2014.00262 PMID: 25325014
59. Sebastian C. Tracking down the origin of cancer: metabolic reprogramming as a driver of stemness and tumorigenesis. Critical reviews in oncogenesis. 2014;19(5):363-82. PMID: 25404151
60. Denkert C, Budczies J, Kind T, Weichert W, Tablack P, Sehouli J, et al. Massspectrometry-basedmetabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 2006;66(22):10795-804. doi: 10.1158/0008-5472.can-06-0755 PMID: 17108116
61. Tedeschi PM, Markert EK, Gounder M, Lin H, Dvorzhinski D, Dolfi SC, et al. Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death Dis. 2013;4:e877. doi: 10.1038/cddis.2013.393 PMID: 24157871
62. Sudarshan S, Shanmugasundaram K, Naylor SL, Lin S, Livi CB, O'Neill CF, et al. Reduced expression of fumarate hydratase in clear cell renal cancer mediates HIF-2alpha accumulation and promotes migration and invasion. PLoSOne. 2011;6(6):e21037. doi: 10.1371/journal.pone.0021037 PMID: 21695080
63. De Berardinis RJ, Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2010;29(3):313-24. doi: 10.1038/onc.2009.358 PMID: 19881548
64. Kurman RJ, Shih Ie M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. The American journal of surgical pathology. 2010;34(3):433-43. doi: 10.1097/PAS. 0b013e3181cf3d79 PMID: 20154587
65. Lim D, Oliva E. Precursors and pathogenesis of ovarian carcinoma. Pathology. 2013;45(3):229-42. doi: 10.1097/PAT.0b013e32835f2264 PMID: 23478230